Monday, December 23, 2024

Gestalt and Pramana Announce Availability of Integrated Digital Pathology Solutions and AI-Powered Platform

Related stories

Doc.com Expands AI developments to Revolutionize Healthcare Access

Doc.com, a pioneering healthcare technology company, proudly announces the development...

Amesite Announces AI-Powered NurseMagic™ Growth in Marketing Reach to Key Markets

Amesite Inc., creator of the AI-powered NurseMagic™ app, announces...

Quantiphi Joins AWS Generative AI Partner Innovation Alliance

Quantiphi, an AI-first digital engineering company, has been named...
spot_imgspot_img

Gestalt Diagnostics, Inc., a leading provider of artificial intelligence (AI) powered digital pathology solutions, and Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, announced a new integrated digital and AI-powered platform for laboratories, health systems, and academic medical centers. The platform offers Gestalt’s embedded Mitotic Cell Counting algorithm and runs in-line on Pramana’s spectral family of scanners.

“The relationship between Gestalt and Pramana has evolved quickly due to our combined commitment to bring advanced technological solutions to healthcare that improve accuracy, efficiency, and stay on top of technological advancements,” said Lisa-Jean Clifford, Gestalt COO and Chief Strategy Officer. “As DICOM becomes more prevalent and the benefits for use in diagnostic and research workflows are being realized, we are continually evolving to provide solutions that support pathologists, scientists, and academics. Working with partners like Pramana, who have similar goals, is what progresses pathology informatics and expands availability and access, advancing healthcare globally.”

Also Read: Eventus WholeHealth and Ambience Healthcare Launch a New AI-Powered Platform for Value-Based Primary Care

The companies’ integrated platform enables fast, accurate, and automated slide scanning with the AI algorithm and image analysis during the processing phase. The algorithm is available for use within Gestalt’s platform, or others, in keeping with Gestalt’s philosophy of being vendor agnostic.

“With a shared commitment to innovation, we are excited to take our collaboration with Gestalt to the next level by offering the first of its kind in-line algorithm,” said Mike Koenig, Pramana’s Chief Business Development Officer. “Our joint solution, with an open DICOM interface, will accelerate diagnosis and drive improved patient outcomes.”

Gestalt will demonstrate the integration of Pramana’s DICOM images and the data associated with Pramana’s Spectral family of scanners within their award-winning platform, PathFlow®, at the Pathology Visions 2023 Conference. Additionally, as an industry early adopter, Gestalt is proud to show the integration with Pramana on Google’s GCP during the event.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img